Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 17, 2013
Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extensionPhilip D Harvey, Cynthia O Siu, Jay Hsu, et al.
The American Journal of Psychiatry|October 31, 2013
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled studyAntony Loebel, Josephine Cucchiaro, Robert Silva, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 14, 2006
Local disruption of the celiac ganglion inhibits substance P release and ameliorates caerulein-induced pancreatitis in ratsMarc D Noble, Joelle Romac, Yu Wang, et al.
Journal of Psychiatric Research|February 21, 2013
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled studyHenry A Nasrallah, Robert Silva, Debra Phillips, et al.
The Journal of Clinical Psychiatry|March 12, 2013
Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label studyJoseph P McEvoy, Leslie Citrome, David Hernandez, et al.
International Clinical Psychopharmacology|March 16, 2021
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trialLenard A Adler, Robert Goldman, Seth C Hopkins, et al.
CNS Spectrums|December 17, 2013
Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension studyLeslie Citrome, Peter J Weiden, Joseph P McEvoy, et al.
Journal of Attention Disorders|August 4, 2019
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom StudySharon B Wigal, Seth C Hopkins, Kenneth S Koblan, et al.
Journal of Child and Adolescent Psychopharmacology|January 30, 2019
Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose TrialRobert L Findling, Lenard A Adler, Thomas J Spencer, et al.
Pageof 2